Greece and China are the biggest factors affecting the market, but earnings season looms as another big element. Among top foreign stocks, a number of drugmakers are slated to deliver big increases in their bottom lines. Mallinckrodt (MNK) is expected to post fiscal third-quarter earnings of $1.82 a share, up 52% from a year ago. While solid, that would mark a second straight period of slowing growth.